Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9809581 Inhibitors of CXCR2

Patent 9809581 was granted and assigned to ChemoCentryx on November, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ChemoCentryx

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

98095810

Patent Inventor Names

Viengkham Malathong0

Xi Chen0

Hiroko Tanaka0

Chao Yu0

Dean R. Dragoli0

Jaroslaw Kalisiak0

Jeffrey McMahon0

Ju Yang0

...

Date of Patent

November 7, 2017

Patent Application Number

153539490

Date Filed

November 17, 2016

Patent Citations Received

‌

US Patent 11945805 Inhibitors of CXCR2

‌

US Patent 11779602 Methods of use for CAR T cells

‌

US Patent 11850262 Compositions and methods for CAR T cell therapy

‌

US Patent 11759480 Compositions and methods for CAR T cell therapy

Patent Primary Examiner

‌

Brian J Davis

Patent abstract

Compounds are provided as inhibitors of CXCR2, having the structure:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9809581 Inhibitors of CXCR2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API